Today

Agents

Chat

Arena

Discover

More

App

Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million - INO News | Rallies

Inovio Pharmaceuticals Q2 Operating Expenses USD 18.6 Million

INO•2026-08-12

Q2 operating expenses and earnings

Aug. 12 (Reuters) - Inovio Pharmaceuticals Q2 net income USD -6 million.

Q2 EPS USD -0.07

Related News

Blackstone’s Argon Holdco disposes of 14,500,000 Corebridge shares worth $491.12 million

CRBG•2026-08-12

Winmill & Co reports acquisition of 12,135 Global Self Storage common shares worth $62,631.41

SELF•2026-08-12

International Tower Hill Mines Q2 FY26 net loss widens to $3.38 million

THM•2026-08-12

Steris director Mohsen Sohi sells 4,058 shares worth $956,597.24

STE•2026-08-12

MySize announces 1-for-8 reverse stock split effective Aug. 13

MYSZ•2026-08-12